divis
beat cent rais estim
adjust ep sept yoy vs cent figur due
revenu higher model tax rate vs last year project
ep estim vs record compani rais guidanc
ep estim revenu
leader infect prevent equip report sept adjust ep vs
year earlier compar report year-over-year period yoy unless otherwis indic cent
figur adjust ep exclud purchas inventori step-up cost intang amort acquisition-
relat integr expens report net incom million per share vs million
revenu increas million price contribut bp constant currenc organ growth
 revenu corpor total fell million revenu
million revenu increas million
adjust gross profit rose million slip bp sale price fx divestitur
off-set revenu mix favor capit equip invest outsourc reprocess see
adjust sg expens million revenu vs expens
rose million vs million equal revenu vs adjust oper profit
yoy million oper margin bp lower adjust tax rate
around vs last year project benefit relat stock-bas compens due
lower tax rate adjust net incom increas million net margin rose
sale vs adjust ep
healthcar product sale infect prevent procedur solut
healthcar provid world-wide includ capit equip washer steam ga steril surgic
pleas see import disclosur end report
tabl light clean chemistri relat mainten instal servic well consum
organ constant currenc basi million backlog increas yoy
million capit equip rose consum increas rose double-digit organ vs
declin last quarter impact divestitur consum busi impact result
novemb servic increas approxim busi replac
remain project consum track procedur volum equip align
building/rehab project oper profit increas million group margin vs
benefit increas volum currenc partial off-set continu invest
healthcar specialti servic rang specialti servic healthcar provid includ
hospit steril servic instrument scope repair linen manag organ
oper profit fell million vs million group margin vs due
invest instrument manag servic im total sever million dollar expand
market outsourc instrument reprocess smaller outsourc project work
gener return month well larger project involv build new facil staf etc
may take year reach optim margin start-up natur longer term project ad
lumpi
appli steril technolog ast contract steril laboratori servic medic
devic manufactur pharmaceut custom other million sale rose
organ increas volum segment core medic devic custom benefit global
facil capac expans group oper profit million group oper
margin revenu vs due revenu growth inflationari price includ
busi contract offset higher labor cost increas product
life scienc ls consist capit equip consum product washer steril
etc equip mainten specialti servic pharmaceut manufactur research
institut lumpi busi due variabl construct deliveri schedul rose organ
million capit equip jump time issu easier comparison
expect second half servic consum ls backlog decreas
million ls longer lead time ls oper profit rose million group
margin fell vs consum highest margin follow servic capit
balanc sheet septemb includ cash equival million equiti billion
debt billion provid debt-to-tot capit ratio vs around
flow oper cfo quarter million vs million year earlier
million first six month vs million activ pursu acquisit
primarili tuck-in note opportun valuat higher repurchas million
share quarter million remain board author share repurchas use
off-set option dilut
sale earn outlook
seek sharehold approv move headquart time uk ireland
brexit risk loss signific benefit headquart countri domicil outsid eu
expect signific competit chang asp busi pend fortiv
acquisit expect mid-single-digit growth equip given backlog strength
pleas see import disclosur end report
divis wellington shield co llc
plc
well around new product launch plan fiscal year primarili capit equip capit
equip strong face tougher comparison move second half hospit
capit spend reportedli continu stabl posit two third busi routin
replac capit spend visibl month remain third construct
expans project month visibl hospit non-hospit build
ambulatori surgeri center micro hospit ast impact decis exit break-even
million annual contract sterilm august alreadi includ guidanc
minim impact expect earn northwel partnership northwel hospit group account
surgic procedur new york project expect gener approxim
million revenu full-year run rate million futur year howev invest
project total approxim million dec ep estim vs
last year previous revenu million
ep estim vs record compani rais guidanc
revenu billion target organ
growth year previous includ benefit price fx favor
first half expect turn neutral back half tariff expect add approxim
million cost suppli chain lead time becom difficult delay anticip
model oper margin record vs gross free cash flow
estim per share respect assum net incom million million
exclud intang amort around million alreadi deduct adjust net
incom figur capital-expenditure million dividend million project million free
cash flow
ep estim revenu billion assum
benefit current invest outsourc project oper margin model bp
revenu long-term target mid-single-digit organ growth double-digit ep
share trade forward ep estim project
year growth rate rate hold due valuat remain posit fundament
includ satisfactori hospit spend potenti outsourc margin improv aid
recent divestitur rel immun polit pressur healthcar compani sell
ev-to-ebitda ratio project ebitda million project
ebitda million share trade price-to-earnings ratio base upon trail report ep
current
global hospit spend environ key variabl synergi deriv approxim
revenu outsid subject compani increas geograph risk well vagari
foreign currenc fluctuat medic technolog compani product obsolesc and/or increas
competit relev risk regulatori issu continu import mani compani product
process subject fda approv and/or inspect
pleas see import disclosur end report
divis wellington shield co llc
plc -- earn model -- novemb
march fiscal year-end
mm ex per share
good sold
good sold
pleas see import disclosur end report
plc -- earn model -- novemb
mm ex per share
march fiscal year-end
total
cfo net incom
after-tax return averag asset
after-tax return averag equiti
pre-tax return average invest capit
pleas see import disclosur end report
